IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026 - 20:22
IN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The company is advancing its next-generation gamma-delta T cell engager platform and expects to release initial animal data later this year.
In its glioblastoma program, IN8bio reported data showing a roughly 97 percent improvement in progression-free survival compared to standard-of-care treatment. The company plans to present updated median overall survival data at the ASCO 2026 conference.
IN8bio will host an R&D Day on May 21, 2026 in New York City to discuss its pipeline and future directions. The company continues to develop innovative gamma-delta T cell therapies designed to target and destroy cancer cells while potentially reducing side effects associated with traditional treatments.
Financial details from the first quarter were not disclosed in the summary, but the company remains focused on advancing its clinical programs and platform technology. IN8bio is headquartered in New York and trades on the Nasdaq under the ticker INAB.
MORE NEWS
July 14, 2026 - 03:57
Lode Gold Announces Non-Brokered Private Placement of $7 Million Financing with Follow-On Investment from Lead Investor Coast CapitalLode Gold Resources Inc. has announced a non-brokered private placement aimed at raising up to $7 million. The company will issue up to 25,925,926 units at a price of $0.27 per unit. Each unit...
July 13, 2026 - 22:27
Horace Mann to announce second-quarter 2026 financial results on August 5SPRINGFIELD, Ill., July 13, 2026 -- Horace Mann Educators Corporation said it will publish its financial results for the second quarter of 2026 on Wednesday, August 5, after the stock market closes...
July 13, 2026 - 03:45
Governor candidate Sara Rodriguez fires campaign head for finance inaccuraciesDemocratic gubernatorial candidate Sara Rodriguez has parted ways with her campaign manager following what her team described as significant financial reporting failures. The decision came to light...
July 12, 2026 - 18:47
A Top H2O America Holder Bought More Stock After an 18% RunA major shareholder in H2O America has increased its position in the company, purchasing additional shares following an 18% rise in the stock price over the past year. The move signals continued...